Regeneron Pharma Files 2023 DEF 14A on Executive Pay

Ticker: REGN · Form: DEF 14A · Filed: 2024-04-25T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, proxy-statement, equity-awards

TL;DR

Regeneron's 2023 DEF 14A is out, detailing exec pay & equity awards.

AI Summary

Regeneron Pharmaceuticals, Inc. filed its DEF 14A on April 25, 2024, for the fiscal year ending December 31, 2023. The filing details executive compensation, including the exclusion and inclusion of certain stock and option awards from the Summary Compensation Table for PEO and Non-PEO NEO members. It also reports on the year-end fair value of unvested equity awards granted during the year.

Why It Matters

This filing provides transparency into how Regeneron Pharmaceuticals compensates its top executives, which can influence investor perception and executive retention.

Risk Assessment

Risk Level: low — A DEF 14A filing is a routine disclosure of executive compensation and corporate governance matters.

Key Numbers

2023 — Fiscal Year (The period covered by the executive compensation details.)
20240425 — Filing Date (The date Regeneron submitted this DEF 14A filing.)

Key Players & Entities

REGENERON PHARMACEUTICALS, INC. (company) — Filer of the DEF 14A
0001308179-24-000577 (filing_id) — Accession number for the filing
20240425 (date) — Filing date
2023-12-31 (date) — Fiscal year end

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes and provide detailed information about matters to be voted on at a shareholder meeting, including executive compensation, director elections, and other corporate governance issues.

What specific compensation details are highlighted for PEO members in this filing?

The filing specifies the exclusion of stock awards and option awards from the Summary Compensation Table for PEO members, and the inclusion of Item 402(v) equity award values for PEO members for the fiscal year 2023.

What information is provided regarding unvested equity awards?

The filing includes details on the year-end fair value of equity awards granted during the year that remained unvested as of the last day of the year for PEO members, and the change in fair value from the prior year's last day to the current year's last day for unvested equity awards for PEO members.

When is the shareholder meeting for which this proxy statement is being issued?

The filing indicates a 'CONFORMED PERIOD OF REPORT: 20240614', suggesting the shareholder meeting or related voting period concludes around June 14, 2024.

What is the company's primary business as indicated by its SIC code?

Regeneron Pharmaceuticals, Inc. has a Standard Industrial Classification (SIC) code of [2834], which corresponds to 'Pharmaceutical Preparations'.

From the Filing

0001308179-24-000577.txt : 20240425 0001308179-24-000577.hdr.sgml : 20240425 20240425160143 ACCESSION NUMBER: 0001308179-24-000577 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 155 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 24876049 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 DEF 14A 1 lregn2024_def14a.htm REGENERON PHARMACEUTICALS, INC. - DEF 14A REGENERON PHARMACEUTICALS, INC. - DEF 14A false 0000872589 DEF 14A 0000872589 2023-01-01 2023-12-31 0000872589 2022-01-01 2022-12-31 0000872589 2021-01-01 2021-12-31 0000872589 2020-01-01 2020-12-31 0000872589 ecd:PeoMember regn:ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:InclusionOfItem402vEquityAwardValuesForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:InclusionOfItem402vEquityAwardValuesForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:VestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:ChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:FairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:TotalInclusionOfEquityValuesForPEOMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:AverageYearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:AverageChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:AverageVestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:AverageChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:PeoMember regn:AverageValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 ecd:NonPeoNeoMember regn:TotalAverageInclusionOfEquityValuesForNonPEONEOsMember 2023-01-01 2023-12-31 0000872589 1 2023-01-01 2023-12-31 0000872589 5 2023-01-01 2023-12-31 0000872589 2 2023-01-01 2023-12-31 0000872589 6 2023-01-01 2023-12-31 0000872589 3 2023-01-01 2023-12-31 0000872589 7 2023-01-01 2023-12-31 0000872589 4 2023-01-01 2